Race may play a role in the waitlist experience, allograft quality and transplant outcomes of patients with autosomal ...
David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback